ArticlePharmaceuticals (Basel, Switzerland)2022

Development of a Hospital Compounded, Taste-Masked, Temozolomide Oral Suspension and 5-Year Real-Life Experience in Treating Paediatric Patients.

Maxime Annereau et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.